Travere News - Web vifor pharma and partner travere therapeutics on friday won an endorsement for approval from the. Q1 2024 revenue increased to $41.4 million from $30.9 million in q1 2023. Web travere therapeutics submits supplemental new drug application to the u.s. Web in this article: Web travere therapeutics will host a conference call and webcast today, monday, may 6, 2024, at 4:30 p.m.
Q1 2024 revenue increased to $41.4 million from $30.9 million in q1 2023. Web travere therapeutics will host a conference call and webcast today, monday, may 6, 2024, at 4:30 p.m. Web in this article: Web travere therapeutics submits supplemental new drug application to the u.s. Web vifor pharma and partner travere therapeutics on friday won an endorsement for approval from the.